Companies House true 2025-09-24 2026-09-30 false 16738945 uk-bus:Director1 2025-09-24 2026-09-30 16738945 uk-bus:Director2 2025-09-24 2026-09-30 16738945 2025-09-24 2026-09-30 16738945 2026-09-30 16738945 uk-bus:EntityHasNeverTraded 2025-09-24 2026-09-30 16738945 uk-bus:FRS102 2025-09-24 2026-09-30 16738945 uk-bus:FullAccounts 2025-09-24 2026-09-30 16738945 uk-bus:AuditExempt-NoAccountantsReport 2025-09-24 2026-09-30 16738945 uk-bus:OrdinaryShareClass1 2025-09-24 2026-09-30 16738945 uk-bus:OrdinaryShareClass2 2025-09-24 2026-09-30 16738945 uk-bus:OrdinaryShareClass3 2025-09-24 2026-09-30 16738945 uk-bus:PreferenceShareClass1 2025-09-24 2026-09-30 16738945 uk-bus:PreferenceShareClass2 2025-09-24 2026-09-30 16738945 uk-bus:PreferenceShareClass3 2025-09-24 2026-09-30 16738945 uk-core:ShareCapitalPreferenceShares 2026-09-30 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 16738945

ASSK PHARMA GROUP UK LTD

Dormant Accounts

30 September 2026

ASSK PHARMA GROUP UK LTD Registered Number 16738945

Balance Sheet as at 30 September 2026

2026
£
Called up share capital not paid
10
Net assets
10
Issued share capital
10 Ordinary Shares of £ 1 each 10
Total Shareholder funds
10

STATEMENTS

  1. For the year ending 30 September 2026 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 1 October 2026

And signed on their behalf by:
Majid Maaroof Ali, Director